Covered recipient · General Payments record
ALAN BRUCE HURSCHMAN
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation Pain Medicine
General Payments · PY2019–2023
$793.74
- Reported across 18 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $321.94 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $160.95 | 2 |
| Collegium Pharmaceutical, Inc. | $40.55 | 2 |
| Azurity Pharmaceuticals, Inc. | $32.28 | 2 |
| Abbott Laboratories | $23.31 | 1 |
| Curonix LLC | $22.36 | 1 |
| SCILEX PHARMACEUTICALS INC. | $22.26 | 1 |
| FORTE BIO-PHARMA LLC | $20.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.31 | 07/14/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1019400631 | CMS |
| Azurity Pharmaceuticals, Inc. | $13.25 | 06/07/2023 | Food and Beverage | Undisputed | 06/30/2026 | 988980851 | CMS |
| Azurity Pharmaceuticals, Inc. | $19.03 | 07/17/2023 | Food and Beverage | Undisputed | 06/30/2026 | 988980855 | CMS |
| Collegium Pharmaceutical, Inc. | $21.43 | 05/23/2023 | Food and Beverage | Undisputed | 06/30/2026 | 987408017 | CMS |
| Collegium Pharmaceutical, Inc. | $19.12 | 08/01/2023 | Food and Beverage | Undisputed | 06/30/2026 | 987416567 | CMS |
| Curonix LLC | $22.36 | 07/25/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1053092377 | CMS |
| Forte Bio-Pharma LLC | $20.23 | 07/11/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1057049537 | CMS |
| Nevro Corp. | $28.51 | 04/07/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1051673829 | CMS |
| Nevro Corp. | $132.44 | 04/12/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1051673811 | CMS |
| Scilex Pharmaceuticals Inc. | $22.26 | 08/10/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1045485979 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.